We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Sperm Analyzer Offers Enhanced Performance, Flexibility, and Standardization

By LabMedica International staff writers
Posted on 28 Jul 2015
Print article
Image: The SQA-VISION Automated Sperm Quality Analyzer (Photo courtresy of Medical Electronic Systems).
Image: The SQA-VISION Automated Sperm Quality Analyzer (Photo courtresy of Medical Electronic Systems).
A new automated sperm-quality analyzer includes enhancement features such as a high-definition touch-screen interface, expanded testing options, and state-of-the-art digital magnification with “click-to-mark” interface. The analyzer will be exhibited by Medical Electronic Systems (MES; Los Angeles, CA, USA) at the Clinical Lab Expo of AACC 2015 (July 26-30; Atlanta, GA, USA).

The “SQA-Vision” analyzer was developed based on 10 years of market feedback and is positioned to augment MES’s line of SQA-V and QwikCheck semen analyzers with a top of the line solution.

“MES has placed greater than 3,750 semen analyzers globally in over 45 countries. This market penetration provided us with the unique opportunity to develop the SQA-Vision based on a wealth of customer feedback. The SQA-Vision will profoundly impact the way semen analysis is conducted in laboratories worldwide with rapid, standardized and accurate test results, customized reporting and greatly expanded testing options which strictly adhere to WHO guidelines,” said Eric Carver, General Manager.

MES developed the SQA-Vision as an intuitive tool for fertility screening, post-vasectomy follow-up, sperm banking, research or detailed IVF assessment. In addition to the predecessor’s testing modes (Fresh, Washed, Frozen, and Post Vasectomy), the SQA-Vision now includes: Density Gradient, Swim Up, Longevity, and Vitality testing options. It also provides a high-resolution visual interface, barcode scanning technology, built-in LIS capability and click-to-mark counters for assessing both sperm vitality and conducting full differential morphology.

“The beauty of the new SQA-Vision is the blend of updated technology, flexibility, and standardized testing. Depending on how semen analysis is conducted in your laboratory, the Vision can be set-up to operate in a wide range of modes. From fully automated routine screening to intensive IVF workups,” said Marcia Deutsch, CEO.

Related Links:

Medical Electronic Systems
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centromere B Assay
Centromere B Test
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.